Impact of Lagtime, Health Insurance Type, and Income Status at Diagnosis on the Long-Term Survival of Adolescent and Young Adult Cancer Patients.

Journal of Adolescent and Young Adult Oncology
Branko CuglievanMichael Roth

Abstract

Purpose: Delays in diagnosis can affect the short-term survival outcomes of adolescent and young adult (AYA) cancer patients. We sought to determine the extent to which delayed diagnosis, health insurance type, and income status are associated with the long-term survival of AYA cancer patients. Methods: We reviewed an institutional cohort of 268 patients age 15-29 years who were diagnosed with the most common neoplasms of the AYA population between 2001 and 2003. We grouped patients by the time of onset of cancer symptomatology to verified diagnosis (lagtime to diagnosis; short or long), health insurance type at diagnosis (public or private), zip-code-based median household income (≤U.S. $50,000 or >U.S. $50,000), and demographic variables. Overall survival (OS) and late OS (LOS; the time from the 5-year anniversary of cancer diagnosis to death from any cause) were the outcomes of interest. Results: OS and LOS did not differ between those with short or long lagtimes to diagnosis for all cancer and for specific cancer types. Among patients with long lagtimes, those with private insurance had significantly better LOS than those with public insurance (p = 0.03). Compared with those who had public insurance, patients who had privat...Continue Reading

References

May 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P W PistersM F Brennan
Feb 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J HeslinM F Brennan
Nov 15, 2002·Pediatric Clinics of North America·Archie Bleyer
Apr 20, 2005·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M A Clark, J M Thomas
Apr 21, 2005·Current Problems in Pediatric and Adolescent Health Care·Archie Bleyer
May 19, 2006·The New England Journal of Medicine·Robert Steinbrook
Jul 10, 2007·European Urology·Eric HuyghePatrick Thonneau
Aug 4, 2007·The Oncologist·Sean MartinArchie Bleyer
May 6, 2008·Pediatric Blood & Cancer·Tam Dang-TanEduardo L Franco
May 23, 2009·Seminars in Oncology·Archie Bleyer, Ronald Barr
Sep 21, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Helen M ParsonsTheresa H M Keegan
Jan 10, 2013·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Megumi J OkumuraDebra S Lotstein
Jun 21, 2013·Psycho-oncology·Faith GibsonDaniel Kelly
Sep 26, 2013·Journal of Adolescent and Young Adult Oncology·Mindy C DerouenTheresa H M Keegan
Jan 21, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George P CanellosVincent T Devita
Jun 4, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ayal A AizerPaul L Nguyen
Nov 25, 2014·Journal of the National Cancer Institute. Monographs·Denise Riedel LewisMargaret R Stedman
Mar 7, 2015·Thyroid : Official Journal of the American Thyroid Association·Thomas J SemradRosemary Cress
Mar 18, 2015·Thyroid : Official Journal of the American Thyroid Association·Theresa H M KeeganPamela L Horn-Ross
Apr 4, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stefanie HiekeMartin Schumacher
May 8, 2015·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Carla J BergAnn Mertens
Jan 31, 2016·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Theresa H M KeeganSally L Glaser
Feb 6, 2016·Cancer·Theresa H M KeeganUNKNOWN National Cancer Institute Next Steps for Adolescent and Young Adult Oncology Epidemiology Working Group
Mar 22, 2016·Cancer Medicine·Matthew KoshyUsama Mahmood
Oct 26, 2016·Journal of Cancer Survivorship : Research and Practice·Jaqueline C AvilaSapna Kaul
Jul 1, 2017·Journal of Adolescent and Young Adult Oncology·Seth J RotzJoseph G Pressey
Aug 18, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ryan D NippElyse R Park
Oct 11, 2017·The Journal of Surgical Research·Laura V BownesElizabeth A Beierle
Nov 21, 2017·International Journal of Radiation Oncology, Biology, Physics·Chirayu G PatelAndrea K Ng
Jan 19, 2018·Journal of Adolescent and Young Adult Oncology·Joemy M RamsayAnne C Kirchhoff

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.